This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Libra Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Ali Munaim Yousif: Innovator in Pharmaceutical Sciences
Introduction
Ali Munaim Yousif is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel therapeutic agents. His work focuses on addressing TRPML1-mediated disorders, which are critical for advancing medical treatments.
Latest Patents
Ali Munaim Yousif holds a patent for "Oxazole TRPML1 agonists and uses thereof." This patent describes oxazole TRPML1 agonists and pharmaceutical compositions that include these agonists. The compounds and compositions outlined in the patent are useful for treating disorders or diseases mediated by TRPML1. He has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Yousif is currently associated with Libra Therapeutics, Inc., where he continues to work on groundbreaking research in the pharmaceutical sector. His expertise and dedication to innovation have positioned him as a valuable asset in his field.
Collaborations
He collaborates with various professionals, including his coworker Maria Pia Catalani, to enhance the scope and impact of his research. Their combined efforts contribute to the advancement of therapeutic solutions.
Conclusion
Ali Munaim Yousif exemplifies the spirit of innovation in the pharmaceutical industry. His work on TRPML1 agonists represents a significant step forward in treating complex medical conditions. His contributions are paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile